Related Experiment Video
Updated: Feb 6, 2026

Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells
Published on: March 18, 2019
Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis
Jun Hee Lee1, Chul Won Yun2, Yong-Seok Han2
1Department of Pharmacology and Toxicology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
Abstract:
Melatonin suppresses tumor development. However, the exact relationship between melatonin and cancer stem cells (CSCs) is poorly understood. This study found that melatonin inhibits colon CSCs by regulating the PrPC -Oct4 axis. In specimens from patients with colorectal cancer, the expressions of cellular prion protein (PrPC ) and Oct4 were significantly correlated with metastasis and tumor stages. Co-treatment with 5-fluorouracil (5-FU) and melatonin inhibited the stem cell markers Oct4, Nanog, Sox2, and ALDH1A1 by downregulating PrPC . In this way, tumor growth, proliferation, and tumor-mediated angiogenesis were suppressed. In colorectal CSCs, PRNP overexpression protects Oct4 against inhibition by 5-FU and melatonin. In contrast, Nanog, Sox2, and ALDH1A1 have no such protection. These results indicate that PrPC directly regulates Oct4, whereas it indirectly regulates Nanog, Sox2, and ALDH1A1. Taken together, our findings suggest that co-treatment with anticancer drug and melatonin is a potential therapy for colorectal cancer. Furthermore, PrPC maintains cancer stemness during tumor progression. Therefore, targeting the PrPC -Oct4 axis may prove instrumental in colorectal cancer therapy.
Insights
Melatonin inhibits colon cancer stem cells by regulating the cellular prion protein (PrPC) and Oct4. This suggests a new therapeutic strategy combining melatonin with chemotherapy for colorectal cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Melatonin is known to suppress tumor development, but its precise role in cancer stem cells (CSCs) remains unclear.
- Colorectal cancer (CRC) progression is linked to cancer stemness, highlighting the need for targeted therapies.
Purpose of the Study:
- To investigate the effect of melatonin on colon CSCs and elucidate the underlying molecular mechanisms.
- To explore the correlation between cellular prion protein (PrPC) and Oct4 expression with CRC metastasis and tumor stage.
Main Methods:
- Analysis of PrPC and Oct4 expression in CRC patient specimens.
- In vitro studies using colorectal CSCs treated with melatonin, 5-fluorouracil (5-FU), or combination therapy.
- Assessment of stem cell markers (Oct4, Nanog, Sox2, ALDH1A1), tumor growth, proliferation, and angiogenesis.
Main Results:
- Melatonin inhibits colon CSCs by regulating the PrPC-Oct4 axis.
- PrPC and Oct4 expression levels correlate with CRC metastasis and tumor stage.
- Combined 5-FU and melatonin treatment downregulated PrPC, inhibiting stem cell markers, tumor growth, proliferation, and angiogenesis.
- PRNP overexpression in colorectal CSCs protected Oct4, but not Nanog, Sox2, or ALDH1A1, from 5-FU and melatonin inhibition.
Conclusions:
- PrPC directly regulates Oct4 and indirectly influences Nanog, Sox2, and ALDH1A1, maintaining cancer stemness in CRC.
- Targeting the PrPC-Oct4 axis presents a promising therapeutic strategy for colorectal cancer.
- Combination therapy with anticancer drugs and melatonin offers a potential treatment approach for CRC.
Related Concept Videos
Master Transcription Regulators
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Regulation of Hematopoietic Stem Cells
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Hypothalamic-Pituitary Axis

